Fungal Meningitis Outbreak

Release: Committee Leaders Request Documents from Drug Compounding Industry Association (December 7, 2012)

Letter to Letter to Scott Karolchyk, President, Board of Directors, International Academy of Compounding Pharmacists, December 7, 2012

 

Hearing: Hearing on “The Fungal Meningitis Outbreak: Could It Have Been Prevented?", Subcommittee on Oversight and Investigations (November 14, 2012)

Opening Statement from Ranking Member Henry Waxman

Memorandum from Ranking Member Henry Waxman

Webcast

 

Release: Committee Issues Subpoena to Head of Facility Linked to Meningitis Outbreak (November 6, 2012)

Subpoena of NECC Director Cadden, November 6, 2012

 

Release: Committee Schedules Hearing on Deadly Meningitis Outbreak (November 5, 2012)

 

Release: Committee Leaders Request Documents Related to Deadly Meningitis Outbreak (October 22, 2012)

Letter to NECC Director Cadden, October 22, 2012

Letter to NECC Attorney Cirel, October 22, 2012

 

Release: Energy and Commerce Leaders Seek All Documents Related to FDA’s Oversight of the NECC Dating Back to 2004 (October 17, 2012)

Letter to FDA Commissioner Hamburg, October 17, 2012

 

Release: Committee Leaders Expand Investigation into Fungal Meningitis Outbreak, Seek Information from Massachusetts Pharmacy Board Responsible for Overseeing New England Compounding Center (October 12, 2012)

Letter to MA Board of Pharmacy Director Coffey, October 12, 2012

 

Release: Committee Leaders Seek More Information From Massachusetts Firm Linked to Deadly Meningitis Outbreak (October 11, 2012)

Letter to NECC Director Cadden, October 11, 2012

 

Release: Committee Leaders Seek Bipartisan Briefing on Fungal Meningitis Outbreak (October 10, 2012)

Letter to CDC Director Frieden, October 9, 2012

Letter to FDA Commissioner Hamburg, October 9, 2012